Fig. 1From: First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three casesPatient response. Left ankle mass of patient #2 pre-treament (a), post two courses of SL-401 (b), and post-HCT (c). Bone marrow CD123 staining and chest CT of patient #3 pre-treatment (d, g), post one course of SL-401 (e, h), and post two courses of SL-401 (f, i)Back to article page